Who are Tachosil fibrin patch's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): EVARREST™, chitosan gel, Pathogen-Reduced Cryoprecipitate, Lipiodol Ultra Fluid with surgical glues, Bioseal Fibrin Sealant, Fibrinogen/thrombin-coated collagen patch.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tachosil-fibrin-patch.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Tachosil fibrin patch — Competitive Intelligence Brief

Tachosil fibrin patch (Tachosil fibrin patch) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic agent; topical fibrin sealant patch. Area: Surgery; Hemostasis.

phase 3 Hemostatic agent; topical fibrin sealant patch Fibrinogen; Factor II (thrombin) Surgery; Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Tachosil fibrin patch (Tachosil fibrin patch) — Ruhr University of Bochum. TachSil is a fibrin-coated collagen patch that promotes hemostasis by providing a scaffold for clot formation and delivering fibrinogen and thrombin to the wound site.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Tachosil fibrin patch TARGET	Tachosil fibrin patch	Ruhr University of Bochum	phase 3	Hemostatic agent; topical fibrin sealant patch	Fibrinogen; Factor II (thrombin)
EVARREST™	EVARREST™	Ethicon, Inc.	marketed	Topical hemostatic agent	Fibrinogen (Factor I) and thrombin (Factor IIa)
chitosan gel	chitosan gel	Ain Shams University	marketed	Biopolymer wound dressing / hemostatic agent
Pathogen-Reduced Cryoprecipitate	Pathogen-Reduced Cryoprecipitate	Weill Medical College of Cornell University	marketed	Blood product / Hemostatic agent
Lipiodol Ultra Fluid with surgical glues	Lipiodol Ultra Fluid with surgical glues	Guerbet	marketed	Radiographic contrast agent / Hemostatic agent
Bioseal Fibrin Sealant	Bioseal Fibrin Sealant	Ethicon, Inc.	marketed	Fibrin sealant / Hemostatic agent
Fibrinogen/thrombin-coated collagen patch	Fibrinogen/thrombin-coated collagen patch	Asan Medical Center	marketed	Hemostatic agent / Surgical sealant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic agent; topical fibrin sealant patch class)

Ruhr University of Bochum · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tachosil fibrin patch — Competitive Intelligence Brief. https://druglandscape.com/ci/tachosil-fibrin-patch. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab